Your browser doesn't support javascript.
loading
Nivolumab in patients with rare head and neck carcinomas: A single center's experience.
Kokkali, Stefania; Ntokou, Anna; Drizou, Maria; Perdikari, Konstantina; Makaronis, Panagiotis; Katsarou, Elena; Koufopoulos, Nektarios; Tzovaras, Alexandros; Ardavanis, Alexandros.
Affiliation
  • Kokkali S; First Medical Oncology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece. Electronic address: stefaniakokkali8@gmail.com.
  • Ntokou A; First Medical Oncology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece.
  • Drizou M; First Medical Oncology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece.
  • Perdikari K; First Medical Oncology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece.
  • Makaronis P; First Medical Oncology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece.
  • Katsarou E; First Medical Oncology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece.
  • Koufopoulos N; Pathology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece.
  • Tzovaras A; First Medical Oncology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece.
  • Ardavanis A; First Medical Oncology Department, Saint-Savvas Anticancer Hospital, L.Alexandras 171, 11521 Athens, Greece.
Oral Oncol ; 101: 104359, 2020 02.
Article in En | MEDLINE | ID: mdl-31300270

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Agents, Immunological / Nivolumab / Head and Neck Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Oral Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Agents, Immunological / Nivolumab / Head and Neck Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Oral Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: United kingdom